Deposition of β-amyloid peptides (Aβ) derived from the proteolytic processing of the amyloid precursor protein (APP) in the brain is a defining pathological hallmark of Alzheimer’s disease (AD)[1]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.